Arum Therapeutics
Novel anticancer and antiviral therapeutics overcoming drug resistance
Seoul, South Korea · Founded 2019
- Headquarters
- Seoul
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- arumtherapeutics.com
About
Arum Therapeutics Inc. is a South Korean biopharmaceutical company focused on developing novel synthetic therapeutics targeting cancer and respiratory rare diseases. Founded in 2019 and headquartered in Seoul, the company is advancing pipeline programs in anticancer agents designed to overcome drug resistance, anticancer immunotherapy combinations, and target-based antiviral agents for conditions including asthma and COPD. Arum Therapeutics applies a target-based drug discovery approach, combining synthetic chemistry and molecular biology expertise to build a diversified oncology and rare disease pipeline aimed at addressing unmet medical needs in markets underserved by existing therapies.
Summary
Arum Therapeutics is a Biotech company based in Seoul, South Korea, founded in 2019.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.